Add time:08/10/2019 Source:sciencedirect.com
Comparative in vitro metabolic activity of human and rat liver fractions toward 5 ring-substituted methylcarbamates are reported. Human liver appeared to be less metabolically active than rat liver toward 4-dimethylamino-3,5-xylyl methylcarbamate (Zectran), 4-dimethylamino-3-cresyl methylcarbamate (Matacil), 4-methylthio-3,5-xylyl methylcarbamate (Mesurol), and 1-naphthyl methylcarbamate (carbaryl). In these studies the human liver metabolized 2-chloro-4,5-xylyl methylcarbamate (Banol) as well as did the rat. Both species produced esssentially the same major metabolites from the carbamates although quantitative differences were observed. Ring hydroxylation and N-dealkylation are the main oxidative metabolic pathways of carbamate metabolism studied in both the human and rat. The human liver produced a few metabolites not seen with the rat liver. The human liver had more difficulty oxidizing the N-methylcarbamate side chain to form the N-hydroxymethylcarbamate derivative of all the carbamates except Mesurol. In both species the major metabolic products from the carbamates retained the OC(O)NC group necessary for acetylcholinesterase inhibition.
We also recommend Trading Suppliers and Manufacturers of 3-Bromophenol methylcarbamate (cas 13538-60-8). Pls Click Website Link as below: cas 13538-60-8 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View